Search Results - "Kiberd, B.A."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    De Novo Donor‐Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis by Kiberd, B. A., Miller, A., Martin, S., Tennankore, K. K.

    Published in American journal of transplantation (01-11-2016)
    “…Screening for de novo donor‐specific antibodies (dnDSA) in stable kidney transplant recipients is routine practice in some centers. Patients with DSA are at…”
    Get full text
    Journal Article
  2. 2

    Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling by Clase, C. M., Mahalati, K., Kiberd, B. A., Lawen, J. G., West, K. A., Fraser, A. D., Belitsky, P.

    Published in American journal of transplantation (01-09-2002)
    “…This study used receiver operating characteristic analysis to investigate the properties of area under the concentration‐time curve during the first 4 h after…”
    Get full text
    Journal Article
  3. 3

    Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later? by Kiberd, B. A., Doucette, K., Vinson, A. J., Tennankore, K. K.

    Published in American journal of transplantation (01-10-2018)
    “…Currently many but not all centers transplant hepatitis C virus (HCV) viremic positive (+) donor kidneys into HCV+ recipients. Directed donation of HCV+ organs…”
    Get full text
    Journal Article
  4. 4

    Donor-Recipient Matching in Kidney Transplant: We're Not There Yet by Vinson, A.J., Tennankore, K.K., Kiberd, B.A.

    Published in Transplantation proceedings (01-07-2021)
    “…Strategic organ allocation is expected to prolong patient and graft survival after transplant. This study explored differences in graft survival when kidneys…”
    Get full text
    Journal Article
  5. 5

    Screening to Prevent Polyoma Virus Nephropathy in Kidney Transplantation: A Cost Analysis by Smith, F., Panek, R., Kiberd, B. A.

    Published in American journal of transplantation (01-09-2009)
    “…Polyoma virus nephropathy is an important cause of graft dysfunction in kidney transplant recipients and screening to prevent disease has been advocated…”
    Get full text
    Journal Article
  6. 6

    BK virus nephropathy in a heart transplant recipient: case report and review of the literature by Barber, C.E.H., Hewlett, T.J.C., Geldenhuys, L., Kiberd, B.A., Acott, P.D., Hatchette, T.F.

    Published in Transplant infectious disease (01-06-2006)
    “…: The human polyomavirus BK virus (BKV) remains latent in the urinary tract and may be reactivated in immunocompromised states. BKV is noted to be the…”
    Get full text
    Journal Article
  7. 7

    Treatment of Hypercholesterolemia With Ezetimibe in the Kidney Transplant Population by Puthenparumpil, J.J., Keough-Ryan, T., Kiberd, M., Lawen, J., Kiberd, B.A.

    Published in Transplantation proceedings (01-03-2005)
    “…Given the high incidence of lipid abnormalities, high burden of cardiovascular disease, and high proportion who do not achieve target levels despite therapy in…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    MDR1 C3435T Polymorphisms Correlate With Cyclosporine Levels in De Novo Renal Recipients by Foote, C.J., Greer, W., Kiberd, B.A., Fraser, A., Lawen, J., Nashan, B., Belitsky, P.

    Published in Transplantation proceedings (01-11-2006)
    “…Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a…”
    Get full text
    Journal Article
  9. 9

    Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients by Singh, D, Kiberd, B.A, West, K.A, Kamal, K, Balbontin, F, Belitsky, P, Lawen, J

    Published in Transplantation proceedings (01-11-2003)
    “…Do patients with high historic peak panel-reactive antibodies (PRA) remain high risk if their PRA levels fall before transplantation? We examined…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Impact of Mycophenolate Mofetil Loading on Drug Exposure in the Early Posttransplant Period by Kiberd, B.A., Puthenparumpil, J.J., Fraser, A., Tett, S.E., Lawen, J.

    Published in Transplantation proceedings (01-06-2005)
    “…Achieving adequate therapeutic levels of immunosuppressive medications is important in rejection prevention. This study examined exposure to mycophenolic acid…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Outcome of the acute glomerular injury in proliferative lupus nephritis by CHAGNAC, A, KIBERD, B. A, FARINAS, M. C, STROBER, S, SIBLEY, R. K, HOPPE, R, MYERS, B. D

    Published in The Journal of clinical investigation (01-09-1989)
    “…Treatment with total lymphoid irradiation (TLI) and corticosteroids markedly reduced activity of systemic lupus erythematosis in 10 patients with diffuse…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Treatment of lupus nephritis with total lymphoid irradiation. Observations during a 12-79-month followup by Strober, S, Fariñas, M C, Field, E H, Solovera, J J, Kiberd, B A, Myers, B D, Hoppe, R T

    Published in Arthritis and rheumatism (01-07-1988)
    “…Seventeen patients with intractable lupus nephritis and nephrotic syndrome were treated with total lymphoid irradiation. Statistically significant improvement…”
    Get more information
    Journal Article